Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

<p><strong>Background</strong> X-linked hypophosphataemia (XLH) is a rare genetic condition passed on through the X chromosome which causes multiple symptoms including weakened teeth, bones, and muscles. Due to the rarity of the condition, little is known about the health outcomes...

Detaylı Bibliyografya
Asıl Yazarlar:	Cole, S, Sanchez-Santos, MT, Kolovos, S, Javaid, MK, Pinedo-Villanueva, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2023

Benzer Materyaller

Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK
Yazar:: Sophie Cole, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Subgroups of adults with X-linked hypophosphataemia: cluster analysis of patient-reported outcome measures of participants in a UK rare diseases cohort
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Patient-reported outcomes of X-linked hypophosphataemia registry participants in the UK
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

A longitudinal study of patient-reported outcomes of RUDY registry participants with X-linked hypophosphataemia in the UK
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

A cross-sectional study of patient-reported outcomes of individuals with X-linked hypophosphataemia within the UK
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Cluster analysis of patient-reported outcome measures of adults with X-linked hypophosphataemia
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Valuation of lost productivity of adults with X-linked Hypophosphataemia and Osteogenesis imperfecta
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
Yazar:: Hawley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

X-linked hypophosphataemia: prevalence and mortality rate within the United Kingdom Clinical Practice Research Datalink
Yazar:: Hawley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

X-linked hypophosphataemia: burden of disease using United Kingdom primary care data
Yazar:: Javaid, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Change in patient-reported outcomes of XLH registry participants in the UK: a longitudinal study
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis
Yazar:: Hawley, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Quality of life in adults with X-linked hypophosphataemia (XLH): Preservation of emotional well-being despite significant limitations in physical domains
Yazar:: Pinedo-Villanueva, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia
Yazar:: Ana Castellano-Martinez, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Valuation of lost productivity for individuals diagnosed with Osteogenesis imperfecta: follow-up findings from the Rudy Cohort Study in the UK
Yazar:: Cole, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
Yazar:: Karine Briot, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Mutations of the PEX regulatory and C-terminal regions cause X-linked hypophosphataemia.
Yazar:: Dixon, P, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
Yazar:: Lothar Seefried, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Hospital admissions of patients with osteogenesis imperfecta in the English NHS
Yazar:: Kolovos, S, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Prevalence of cardiovascular disease events and determinants in patients with x-linked hypophosphatemia
Yazar:: Maronga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Prevalence and risk factors of hypertension among patients with X-linked hypophosphatemia
Yazar:: Maronga, C, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study
Yazar:: Takuo Kubota, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Description of hospital use by patients with osteogenesis imperfecta in the English NHS
Yazar:: Kolovos, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study
Yazar:: Raja Padidela, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Rare genetic diseases of the bone tissue: the case of a family with osteogenesis imperfecta and X-linked hypophosphataemia
Yazar:: Irina Yu. Popova, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Hypophosphataemia masquerading as ankylosing spondylitis
Yazar:: Wordsworth, B, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Identification of a Novel Missense Mutation of the PHEX Gene in a Large Chinese Family with X-Linked Hypophosphataemia
Yazar:: Yanting Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH).
Yazar:: Vrinda Saraff, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Hypophosphataemia: An under-recognized cause of spondyloarthropathy
Yazar:: Wordsworth, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Improvements with burosumab treatment in an early access programme for adults with X-linked hypophosphataemia: A case series of three patients
Yazar:: Julia Day, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
Yazar:: Maria Luisa Brandi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

A literature review of the healthcare resource use and productivity burden of X-linked hypophosphatemia
Yazar:: Pinedo Villanueva, R, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
Yazar:: Wainwright, E, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Early hypophosphataemia in at risk newborns. Frequency and magnitude
Yazar:: Gerardo Bustos Lozano, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Isolated hypophosphataemia as an early marker of primary hyperparathyroidism
Yazar:: John Alexander, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey
Yazar:: Li Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2025-03-01)

Valuation of lost productivity for people with osteogenesis imperfecta: preliminary results from the RUDY cohort
Yazar:: Cole, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Severe asymptomatic hypophosphataemia in a child with T-acute lymphoblastic leukaemia
Yazar:: Zakaria, N.H., ve diğerleri
Baskı/Yayın Bilgisi: (2017)

An uncommon cause for severe hypophosphataemia after transsphenoidal pituitary surgery
Yazar:: Ramamani Mariappan, ve diğerleri
Baskı/Yayın Bilgisi: (2014-05-01)

Acute onset quadriparesis following oesophagectomy due to isolated hypophosphataemia
Yazar:: Vibhavari M Naik, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)